Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
2003 1
2006 1
2007 1
2008 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.
Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ. Ernst M, et al. Neuropsychopharmacology. 1997 Apr;16(4):276-84. doi: 10.1016/S0893-133X(96)00243-6. Neuropsychopharmacology. 1997. PMID: 9094145 Clinical Trial.
Selegiline, at low dose, is a selective monoamine oxidase inhibitor type B (MAOI-B). After 2-week placebo baseline, 36 ADHD adults were randomized to 6-week placebo or 20 mg/day or 60 mg/day selegiline, followed by 2-week posttreatment placebo. Twenty-seven subjects …
Selegiline, at low dose, is a selective monoamine oxidase inhibitor type B (MAOI-B). After 2-week placebo baseline, 36 ADHD adults we …
Antidepressants for smoking cessation.
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Hughes JR, et al. Cochrane Database Syst Rev. 2014 Jan 8;2014(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Cochrane Database Syst Rev. 2014. PMID: 24402784 Free PMC article. Updated. Review.
The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methionine (SAMe); selegiline; sertraline; St. John's wort; tryptophan; venlafaxine; and zimeledine. ...Evidence also suggests that bupropio …
The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methion …
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
Dingemanse J, Kneer J, Wallnöfer A, Kettler R, Zürcher G, Koulu M, Korn A. Dingemanse J, et al. Clin Neuropharmacol. 1996 Oct;19(5):399-414. doi: 10.1097/00002826-199619050-00003. Clin Neuropharmacol. 1996. PMID: 8889283 Clinical Trial.
Several variables (DHPG, platelet serotonin) suggested that selegiline has some MAO-A inhibitory activity. This became particularly apparent upon addition of selegiline to moclobemide treatment; i.e., the effects of combined moclobemide and selegiline …
Several variables (DHPG, platelet serotonin) suggested that selegiline has some MAO-A inhibitory activity. This became particu …
Lack of adverse interactions between concomitantly administered selegiline and citalopram.
Laine K, Anttila M, Heinonen E, Helminen A, Huupponen R, Mäki-Ikola O, Reinikainen K, Scheinin M. Laine K, et al. Clin Neuropharmacol. 1997 Oct;20(5):419-33. doi: 10.1097/00002826-199710000-00006. Clin Neuropharmacol. 1997. PMID: 9331518 Clinical Trial.
We have evaluated the risk for pharmacokinetic and/or pharmacodynamic interactions of concomitantly administered selegiline, a selective monoamine oxidase type B inhibitor, and citalopram, a widely used selective serotonin uptake inhibitor antidepressant. ...The rel …
We have evaluated the risk for pharmacokinetic and/or pharmacodynamic interactions of concomitantly administered selegiline, a select …
Antidepressants for smoking cessation.
Hughes JR, Stead LF, Lancaster T. Hughes JR, et al. Cochrane Database Syst Rev. 2003;(2):CD000031. doi: 10.1002/14651858.CD000031. Cochrane Database Syst Rev. 2003. PMID: 12804385 Updated. Review.
The drugs include bupropion; doxepin; fluoxetine; imipramine; moclobemide; nortriptyline; paroxetine; selegiline; sertraline, tryptophan and venlafaxine. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register which includes trials indexed in MEDL …
The drugs include bupropion; doxepin; fluoxetine; imipramine; moclobemide; nortriptyline; paroxetine; selegiline; sertraline, tryptop …
A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia.
Costa AM, Lima MS, Mari Jde J. Costa AM, et al. Sao Paulo Med J. 2006 Sep 7;124(5):291-7. doi: 10.1590/s1516-31802006000500012. Sao Paulo Med J. 2006. PMID: 17262163 Free article. Review.
The agents used were: bromocriptine, cabergoline, cyproheptadine, amantadine, shakuyaku-kanzo-to, sildenafil and selegiline. DISCUSSION: There was no evidence that those agents had proper efficacy in treating the antipsychotic-induced sexual dysfunction. ...
The agents used were: bromocriptine, cabergoline, cyproheptadine, amantadine, shakuyaku-kanzo-to, sildenafil and selegiline. DISCUSSI …
The effects of antidepressants in Parkinson's disease: a meta-analysis.
Frisina PG, Tenenbaum HR, Borod JC, Foldi NS. Frisina PG, et al. Int J Neurosci. 2008 May;118(5):667-82. doi: 10.1080/00207450701239418. Int J Neurosci. 2008. PMID: 18446583

Altogether, 24 placebo-controlled trials qualified for inclusion and revealed that tricyclic antidepressants (TCAs) had a greater antidepressant effect relative to selective serotonin reuptake inhibitors (SSRIs), Qb(1) = 8.87, p < .01, and the mono-amine-oxidase inhibit

…
Altogether, 24 placebo-controlled trials qualified for inclusion and revealed that tricyclic antidepressants (TCAs) had a greater antidepres …
Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Robinson DS, Gilmor ML, Yang Y, Moonsammy G, Azzaro AJ, Oren DA, Campbell BJ. Robinson DS, et al. Psychopharmacol Bull. 2007;40(3):15-28. Psychopharmacol Bull. 2007. PMID: 18007565
OBJECTIVE: Selegiline transdermal system (STS) is efficacious for the treatment of major depressive disorder (MDD). ...CONCLUSIONS: STS, an monoamine oxidase inhibitor antidepressant that potentiates the three major monoamine neurotransmitters (serotonin, norepineph …
OBJECTIVE: Selegiline transdermal system (STS) is efficacious for the treatment of major depressive disorder (MDD). ...CONCLUSIONS: S …

Searches related to "selegiline serotonin"